BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30852550)

  • 1. Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy.
    Freeman K; Willis BH; Fraser H; Taylor-Phillips S; Clarke A
    BMJ Open; 2019 Mar; 9(3):e027428. PubMed ID: 30852550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis.
    An YK; Prince D; Gardiner F; Neeman T; Linedale EC; Andrews JM; Connor S; Begun J
    Med J Aust; 2019 Nov; 211(10):461-467. PubMed ID: 31680263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
    Conroy S; Hale MF; Cross SS; Swallow K; Sidhu RH; Sargur R; Lobo AJ
    J Clin Pathol; 2018 Apr; 71(4):316-322. PubMed ID: 28844038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults.
    Dajti E; Frazzoni L; Iascone V; Secco M; Vestito A; Fuccio L; Eusebi LH; Fusaroli P; Rizzello F; Calabrese C; Gionchetti P; Bazzoli F; Zagari RM
    Aliment Pharmacol Ther; 2023 Dec; 58(11-12):1120-1131. PubMed ID: 37823411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test accuracy of faecal calprotectin for inflammatory bowel disease in UK primary care: a retrospective cohort study of the IMRD-UK data.
    Freeman K; Taylor-Phillips S; Willis BH; Ryan R; Clarke A
    BMJ Open; 2021 Feb; 11(2):e044177. PubMed ID: 33619196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study.
    Walker GJ; Chanchlani N; Thomas A; Lin S; Moore L; Heerasing NM; Hendy P; Abdelrahim M; Mole S; Perry MH; Mcdonald TJ; Bewshea CM; Hart JW; Russell RK; Ahmad T; Goodhand JR; Kennedy NA
    Arch Dis Child; 2020 Oct; 105(10):957-963. PubMed ID: 32424002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
    Högberg C; Karling P; Rutegård J; Lilja M
    Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing outcomes from tailored meta-analysis with outcomes from a setting specific test accuracy study using routine data of faecal calprotectin testing for inflammatory bowel disease.
    Freeman K; Willis BH; Ryan R; Taylor-Phillips S; Clarke A
    BMC Med Res Methodol; 2022 Jul; 22(1):192. PubMed ID: 35820893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.
    Mowat C; Digby J; Strachan JA; Wilson R; Carey FA; Fraser CG; Steele RJ
    Gut; 2016 Sep; 65(9):1463-9. PubMed ID: 26294695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: meta-analysis.
    Petryszyn P; Staniak A; Wolosianska A; Ekk-Cierniakowski P
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1306-1312. PubMed ID: 31464777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal calprotectin in suspected paediatric inflammatory bowel disease.
    Degraeuwe PL; Beld MP; Ashorn M; Canani RB; Day AS; Diamanti A; Fagerberg UL; Henderson P; Kolho KL; Van de Vijver E; van Rheenen PF; Wilson DC; Kessels AG
    J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):339-46. PubMed ID: 25373864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease.
    Zhang W; Wong CH; Chavannes M; Mohammadi T; Rosenfeld G
    BMJ Open; 2019 Apr; 9(4):e027043. PubMed ID: 30987989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.
    Heida A; Van de Vijver E; van Ravenzwaaij D; Van Biervliet S; Hummel TZ; Yuksel Z; Gonera-de Jong G; Schulenberg R; Muller Kobold A; van Rheenen PF;
    Arch Dis Child; 2018 Jun; 103(6):565-571. PubMed ID: 29514815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years.
    Kennedy NA; Clark A; Walkden A; Chang JC; Fascí-Spurio F; Muscat M; Gordon BW; Kingstone K; Satsangi J; Arnott ID; Lees CW
    J Crohns Colitis; 2015 Jan; 9(1):41-9. PubMed ID: 25135754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
    von Roon AC; Karamountzos L; Purkayastha S; Reese GE; Darzi AW; Teare JP; Paraskeva P; Tekkis PP
    Am J Gastroenterol; 2007 Apr; 102(4):803-13. PubMed ID: 17324124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis.
    Henderson P; Anderson NH; Wilson DC
    Am J Gastroenterol; 2014 May; 109(5):637-45. PubMed ID: 23670113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study.
    Turvill J; Aghahoseini A; Sivarajasingham N; Abbas K; Choudhry M; Polyzois K; Lasithiotakis K; Volanaki D; Kim B; Langlands F; Andrew H; Roos J; Mellen S; Turnock D; Jones A
    Br J Gen Pract; 2016 Jul; 66(648):e499-506. PubMed ID: 27266863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.